Received Feb 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y009094 | — |
No additional AE reported.; Nurse reports expired VAQTA was administered to one patient. Product expired 11/29/2025 and was administered 1/14/2026.; This spontaneous report was received from a registered nurse (R.N.) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, past medications and concomitant medications were not reported. On 14-Jan-2026 (also reported as 14-Jan-2025, conflicting information), the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) suspension for injection, lot number: Y009094, expiration date: 29-Nov-2025 (exact dose, dose number, route of administration, anatomical location were not reported), for prophylaxis (Expired product administered). The vaccine did not experience any temperature excursions through date of administration. No additional adverse event was reported.